Focused Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8	Closed	-$9	–	612
2023 Q4	$9	Hold	8	–	–	﹤0.01%	1012
2023 Q3	$9	Hold	8	–	–	﹤0.01%	1021
2023 Q2	$11	Hold	8	–	–	﹤0.01%	1055
2023 Q1	$12	Hold	8	–	–	﹤0.01%	1034
2022 Q4	$9	Hold	8	–	–	﹤0.01%	1077
2022 Q3	$0	Hold	8	–	–	﹤0.01%	1014
2022 Q2	$0	Hold	8	–	–	﹤0.01%	1012
2022 Q1	$0	Hold	8	–	–	﹤0.01%	1055
2021 Q4	$0	Hold	8	–	–	﹤0.01%	1055
2021 Q3	$0	Hold	8	–	–	﹤0.01%	1057
2021 Q2	$0	Hold	8	–	–	﹤0.01%	995
2021 Q1	$0	Hold	8	–	–	﹤0.01%	968
2020 Q4	$0	Hold	8	–	–	﹤0.01%	872
2020 Q3	$0	Hold	8	–	–	﹤0.01%	834
2020 Q2	$0	Hold	8	–	–	﹤0.01%	806
2020 Q1	$0	Hold	8	–	–	﹤0.01%	750
2019 Q4	$0	Hold	8	–	–	﹤0.01%	752
2019 Q3	$0	Hold	8	–	–	﹤0.01%	751
2019 Q2	$0	Hold	8	–	–	﹤0.01%	773
2019 Q1	$0	Buy	+8	New	+$10	﹤0.01%	742

Other funds holding LCTX